Aspire Biopharma Holdings Inc (ASBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,538 | 4,464 | 3,340 | -26 | N/A |
| Other Working Capital | 1,034 | 687 | -432 | -213 | N/A |
| Other Operating Activity | 9,449 | -5,804 | -4,317 | 0 | 0 |
| Operating Cash Flow | $-2,055 | $-653 | $-1,409 | $-239 | $N/A |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 13,781 | 284,916 | -294,688 | 0 | 0 |
| Investing Cash Flow | $13,781 | $284,916 | $-294,688 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,711 | N/A | -299 | 239 | N/A |
| Common Stock Issued | N/A | N/A | 297,145 | N/A | N/A |
| Common Stock Repurchased | -13,781 | -284,916 | N/A | N/A | N/A |
| Other Financing Activity | 343 | 156 | -253 | 0 | 0 |
| Financing Cash Flow | $-11,727 | $-284,760 | $296,594 | $239 | $N/A |
| Beginning Cash Position | N/A | 497 | N/A | N/A | N/A |
| End Cash Position | N/A | 0 | 497 | N/A | N/A |
| Net Cash Flow | $0 | $-497 | $497 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,055 | -653 | -1,409 | -239 | N/A |
| Free Cash Flow | -2,055 | -653 | -1,409 | -239 | 0 |